Evidence map›Paper›PMID 20464461›Full record

Trial reportPharmaceutical research2011

In vivo, in situ imaging of microneedle insertion into the skin of human volunteers using optical coherence tomography.

Siôn A Coulman, James C Birchall, Aneesh Alex, Marc Pearton, Bernd Hofer, Conor O'Mahony, Wolfgang Drexler, Boris Považay

Open access · greenAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Pharmaceutical research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 127 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Hydrogel-forming microarray patch mediated transdermal delivery of tetracycline hydrochloride.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  13. Review
  14. A 3D-printed transepidermal microprojection array for human skin microbiome sampling.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  15. Review
  16. Article
  17. Current trends in polymer microneedle for transdermal drug delivery.International journal of pharmaceutics · 2020
    Review
  18. Article
  19. Laser facilitates week-long sustained transdermal drug delivery at high doses.Journal of controlled release : official journal of the Controlled Release Society · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Siôn A CoulmanGene Delivery Research Group, Welsh School of Pharmacy, Cardiff University, Cardiff, CF10 3NB, UK. coulmansa@cardiff.ac.uk
James C Birchall
Aneesh Alex
Marc Pearton
Bernd Hofer
Conor O'Mahony
Wolfgang Drexler
Boris Považay
Cardiff University · GBMedical University of Vienna · ATUniversity College Cork · IE

Funding

Biotechnology and Biological Sciences Research Council
6 · The paper itself

Abstract

purposeTo gather sub-surface in situ images of microneedle-treated human skin, in vivo, using optical coherence tomography (OCT). This is the first study to utilise OCT to investigate the architectural changes that are induced in skin following microneedle application.

methodsSteel, silicon and polymer microneedle devices, with different microneedle arrangements and morphologies, were applied to two anatomical sites in human volunteers following appropriate ethical approval. A state-of-the-art ultrahigh resolution OCT imaging system operating at 800 nm wavelength and <3 µm effective axial resolution was used to visualise the microneedle-treated area during insertion and/or following removal of the device, without any tissue processing.

resultsTransverse images of a microneedle device, in situ, were captured by the OCT system and suggest that the stratified skin tissue is compressed during microneedle application. Following removal of the device, the created microchannels collapse within the in vivo environment and, therefore, for all studied devices, microconduit dimensions are markedly smaller than the microneedle dimensions.

conclusionsMicrochannels created in the upper skin layers by microneedles are less invasive than previous histology predicts. OCT has the potential to play a highly influential role in the future development of microneedle devices and other transdermal delivery systems.

Indexed as

NeedlesTomography, Optical CoherenceAdultDrug Delivery SystemsEquipment DesignHumansInjections, IntradermalMaleMicroinjectionsMicroscopy, Electron, ScanningSkinSurface PropertiesTechnology, PharmaceuticalYoung Adult

Identifiers

PMID20464461
OpenAlexW2133160112

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.